Handicapping stocks and horses have many similarities. Finding the winner can be tough in big fields. Diagnostic testing has much competition and varied technologies to draw from. Nothing short of "best of breed" for Trinity, either through internal development or acquisition. "Best of Breed" sells itself when pricing and availability are not an issue. Our "Best of Breed" pipeline revenue absolutely dwarfs current revenue.
It looks like we have buying interest and patient accumulation right now. The bid is being raised for those who wish to take profits off these highs. Like AM/PM - too much good stuff! This is as cheap as she's gonna get. I know others have done the math. This is no time to take profits imo. Over the next couple trading days, I see the patient buying and accumulation transitioning into competative buying mode and a subsequent 5-8% pop into this action. Just an observation and feeling from this long time investor. G/L longs